tradingkey.logo
tradingkey.logo
Search

Polaryx Therapeutics Ord Shs

PLYX
Add to Watchlist
2.110USD
-0.030-1.40%
Market hours 09/24, 13:34(ET)
105.18MMarket Cap
LossP/E TTM

PLYX Financials

See Polaryx Therapeutics Ord Shs's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
105.18M
Dividend TTM
0.00
P/E TTM
-12.16
EPS TTM
-0.17
Revenue
--
Net Profit
0.00
ROE
0.00%
ROA
0.00%

Polaryx Therapeutics Ord Shs Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q3
Financial Indicators
EPS
---0.03
---0.05
---0.03
Net Profit
---1.38M
---2.54M
---1.43M
Operating profit
---1.38M
---1.96M
---974.00K
Net Profit
---1.38M
---2.54M
---1.43M
Current assets
--11.81M
--3.50M
--5.98M
Total current liabilities
--873.00K
--1.01M
--682.00K
Total assets
--11.81M
--3.50M
--5.98M
Total liabilities
--873.00K
--1.01M
--682.00K
Total equity
--10.94M
--2.49M
--5.30M
Net operating income
---1.37M
---2.06M
----
Net financing
--9.83M
--0.00
----

FAQs

What are the current assets of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its current assets were 5.00M, with a year-on-year change of 116.03.

What are the total assets of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its total assets of Polaryx Therapeutics Ord Shs were 5.00M, with a year-on-year change of 116.03.

What are the total liabilities of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its total liabilities of Polaryx Therapeutics Ord Shs were 289.00K, with a year-on-year change of -72.16.

What is the total equity of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its total equity of Polaryx Therapeutics Ord Shs was 4.71M, with a year-on-year change of 268.99.

What is the net operating income of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its net operating income of Polaryx Therapeutics Ord Shs was -4.35M, with a year-on-year change of -15.10.

What is the net financing of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its net financing of Polaryx Therapeutics Ord Shs was 7.19M, with a year-on-year change of 5518.75.

What is the net income of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its net income was -30.36M, with a year-on-year change of -703.28.

What is the operating profit of Polaryx Therapeutics Ord Shs?

According to Polaryx Therapeutics Ord Shs's FY2024 earnings report, its operating profit was -4.35M, with a year-on-year change of -15.10.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.